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Binding of penicillin to the DD-carboxypeptidase of the unstable spheroplast L-form of Proteus 
mirabilis results in the rapid formation of a modified enzyme-inhibitor complex which in turn under- 
goes rapid decay into reactivated enzyme and an antibiotically inactive penicillin degradation product. 
Major antibiotic metabolites recovered from such interactions were benzylpenicilloic acid and 
phenoxymethylpenicilloic acid from benzylpenicillin and phenoxymethylpenicillin, respectively, 
suggesting a second enzymic function of the DD-carboxypeptidase as a penicillinase of low efficiency. 
Statistical analyses made with the help of a linear regression program show that the enzyme interacts 
with the substrate UDP-N-acetylmuramoyl-~-alanyl-~-y-glutamyl-(~)-meso-2,6-d~aminop~melyl-(~)- 
D-alanyl-D-alanine and either benzylpenicillin or carbenicillin in a non-competitive manner. 
In the presence of penicillin at high concentration 
(0.34 mM) the gram-negative bacterium Proteus miru- 
bilis is able to grow as an unstable L-form and to 
synthesize a cell-wall peptidoglycan of apparently 
normal chemical composition. Therefore, DD-carb- 
oxypeptidases and transpeptidases, the specific en- 
zymic targets of the inhibitory action of penicillin 
of the model of reaction developed for the exocellular 
DD-cdrboxypeptidases-transpeptidases of Streptomy- 
ces strain R61 [4,5] and Actinomadura strain R39 [6]. 
We also describe the reaction products into which 
penicillin is degraded during this interaction. 
on bacterial peptidoglycan synthesis, must continue 
to function in this organism in spite of the presence MATERIALS AND METHODS 
of the antibiotic [1,2]. A membrane-bound DD- Enzyme 
carboxypeptidase of the unstable Proteus L-form 
has been highly purified. Its preliminary characteriza- 
tion indicated that the enzyme was only moderately 
sensitive to penicillin, with a low stability of the 
enzyme-inhibitor complex and an apparent non- 
competitive mode of inhibition [3]. 
The validity of these notions has been examined 
by computer analyses of the kinetics of interaction 
of the purified Proteus L-form DD-carboxypeptidase 
with benzylpenicillin and carbenicillin on the basis 
Two preparations of the DD-carboxypeptidase of 
the unstable spheroplast L-form of P. mirabilis, 
strain 19, were used. Preparation A had been obtained 
by affinity chromatography on ampicillin bound to 
succinyl-aminododecyl-cellulose [3]. Preparation B 
had been subsequently submitted to preparative iso- 
electric focusing on Sephadex G-75 with ampholine, 
pH 5-8, at 1200 V and 15 W for 36 h (isoelectric 
point pH 5.9, W. Schilf and H. H. Martin, unpublish- 
ed data). On gel electroDhoresis in the mesence of v 
Abbreviations. UDP-MurNAc-pentapeptide or UDP-MurNAc- 
LAla-DGlu(Azpm-DAla-DAla), UDP-N-acetylmuramoyl-L-alanyl- 
~-y-g~utamy~-(~~)-meso-2 ,6-d~am~nop~melyl - (~) -~-a~anyl -~-a lan~ne;  
Hepes, N-2-hydroxymethylpiperazine-N’-2-ethanesulfonic acid ; 
Genapol X-300, isotridecanolpolyglycol ether (f i = 10). 
p-lactamase (EC 3.5.2.6). 
sodium dodecylsulfate, the enzyme gave rise to a 
single protein band with an apparent M ,  Value Of 
43 000. Both enzyme preparations A and B, when 
used for the experiments described here, had specific 
tively. One U catalyses the release of 1 pmol D-alanine 
Enzyme.7. DD-Carboxypeptidase (EC 3.4.12.6); penicillinase or activities Of about o‘2 and 0.75 U/mg protein, respec- 
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per min from UDP-MurNAc-LAla-DGlu(Azpm-DAla- Assuming that during the interaction between 
DAla) under conditions of enzyme saturation. Enzyme enzyme, penicillin and DAla-DAla-terminated peptide 
assays were carried out either by enzymic determina- substrate (S), the ternary complex EIS is formed, 
tion of D-alanine liberated from non-radioactive a non-competitive model can be represented as follows : 
substrate [2] or by measurement of the amount of 
~-['~C]alanine released from UDP-MurNAc-LAla- 
~ G l u ( A ~ p m - ~ A l a - ~  [14C]Ala). 
E + 1 5  EI k EI* 
+ + 
S S - ~~ 
E + degraded antibiotic (P') 
/I-Lactam Antibiotics 
Radioactive /I-lactams used were ['4C]benzyl- 
penicillin (with the label on the carbonyl group of-the 
phenylacetyl side chain, 54 Ci/mol) from the Radio- 
chemical Centre, Amersham and phenoxymethyl- 
[3H]penicillin (with the label on the P-methyl group, 
100 Ci/mol); this tritiated B-lactam was a gift from 
Prof. E. P. Abraham [7]. ''C-labelled benzylpenicilloic 
acid was prepared from ['4C]benzylpenicillin by reac- 
tion with penicillinase (penicillinase Riker purchased 
from Serva Feinbiochemica, Heidelberg, F.R.G.). 
Chromogenic cephalosporin 87-312 [3-(2,4-dinitro- 
styryl) - (6R,7R) -7- (2-thienylacetamido) - ceph-3-em-4- 
carboxylic acid, E isomer] was a gift from Dr O'Callag- 
han (Glaxo Research Ltd, U.K.) [8]. 
Penicillin Metabolites 
Separation of penicillin from its degradation 
products was performed by thin-layer chromatog- 
raphy on silica gel plates in three solvent systems: 
(a) l-butanol/H20/acetic acid/ethanol (10/4/3/3 ; 
v/v/v/v) ; (b) HzO/l -butanol/acetic acid (50/40/10, v/v/v, 
upper phase) and (c) chloroform/methanol/acetic acid 
(88/10/2, v/v/v) [9], and by high-voltage paper electro- 
phoresis in collidine/acetic acid/HzO (9.1/2.65/1000, 
v/v/v) at pH 6.5 [lo]. 
Quantitative analysis of penicillin metabolites by 
column chromatography on Chromobeads type B 
cation-exchange resin was carried out as described 
by Adriaens et al. [ l l ]  and Coyette et al. [12]. 
COMPUTER ANALYSES 
OF INTERACTION BETWEEN ENZYME, SUBSTRATE 
AND PENICILLIN 
General Treatment : Non-competitive Model 
The interaction between penicillin (I) and the 
extracellular DD-carboxypeptidases-transpeptidases 
(E) of both Streptomyces R61 and Actinomadura R39 
is a three-step reaction : 
E + I $? EI -% EI* k4, E + degraded antibiotic 
with K = the dissociation constant of the binary 
complex EI and k3 and k4 = first-order rate constants 
[4,61. 
k4K 
k3 -t- k4 
K ,  11 11 K;. with Ki = 
ES + I S E I S  
ki 1 
E + degraded peptide (P). 
The four steps in the loop are rapid equilibrium 
processes [5]. Under conditions where [I] 9 [El and 
for values of time such that the reaction has reached 
the steady state, the ratio V/v (with V the maximal 
velocity of formation of P at saturating concentration 
of substrate and in the absence of antibiotic, and v 
the velocity of the reaction either in the absence or 
the presence of penicillin and with nonsaturating 
concentrations of substrate) is given by the following 
equation [5] : 
In order to estimate the V ,  K,, Ki and K' values 
by computer analyses, Eqn (1) has been transformed 
into : 
yth = (1/V)th = U X  + bxz + C + dz (2) 
with yth = the theoretical value of l / v ,  x = l/[S], 
= [I], a = Km/V, b = Km/VKi, c = I / V  and d 
= l/VK'. 
Estimation of the a, b, c, d Coefficient Values 
The error function 
i = n  
wf bi - yth)' 
i = l  
with y i  = the experimental value of l / v ,  n = number 
of y i  values and w i  = the weight of each y i  value, has 
been minimized by calculating the a, b, c and d co- 
efficients as shown below. In the present experiments, 
similar amounts of P were measured in all cases and 
for this purpose, the incubation times were adjusted 
depending upon the substrate concentrations. Conse- 
quently, all the experimental v values were affected by 
the same relative error and wi  was estimated as the reci- 
procal l / y i .  
On the basis that 
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Table 1. Conditions of interaction between enzyme, substrate and penicillin 
In all cases, the incubation times at 37 "C were such that about the same amounts (2-4 nmol) of UDP-MurNAc-pentapeptide were 
hydrolyzed 
Expt Temp. Enzyme prepn Substrate concn Antibiotic concn Determination of Number of 
free D-alanine measurements 
"C mM w 
_ _ _ _ - _ _  - - ~ ~ _ _ _ _  
Benzylpenicillin 
1 30 A 0.38, 0.57, 0.9, 1.32, 2.57 0, 0.5, 1, 2 radioactive 20 
2 31 A 0.6, 0.9, 1.25, 2.5 0, 0.25, 0.5, 1, 1.5 enzymic 20 
3 37 B 0.22, 0.33, 0.5, 0.8$ 2, 5 ,  10 0, 0.3, 0.6, 0.9, 1.5 enzymic 35 
Carbenicillin 
4 37 B 0.33, 0.5, 0.8, 2, 5, 10 0, 5, 30, 20 enzymic 24 
is the vector of the various coefficients to be determin- 
ed, 
y =  --t ( )  
Y n  
is the vector of the measured variables, A the linkage 
matrix, AT the transposed matrix A and w2 the 
diagonal matrix of the wf values, the equation system 
representing the measurements is ?th = A@ and the 
solution to the problem of minimization is given by 
3 = (ATw2A)-' ATw2?. (3) 
In order to solve the Eqn (3), a linear regression 
program was written in Fortran IV and the data 
were analyzed on a Modcomp 11/10 minicomputer. 
The program is general and allows equations with k 
variables and 1 parameters to be analyzed. The same 
program also computes the residual variance (s&) 
and 1/s& (ATw2A)ii' values (see below). The inverted 
matrix was needed for this latter calculation and there- 
fore a matrix inversion subroutine was used instead 
of a linear equation resolution subroutine. 
Residual Variance and Confidence Interval 
The residual variance is given by the equation 
c wTyf - c7' 
SOR = n - m  
with o1 = j?ATw2$ and m = number of parameters 
to be determined (i.e. four in the present case). 
The Student variable was then calculated for each 
parameter a, b, c and d on the basis of (e - &)/li 
with e = the experimental value of one given coef- 
ficient as determined by the program, E = the real 
value of the same coefficient and li = 1/&R [ATw2A] ii' . 
Finally, the confidence interval at 0.99 was computed 
as e - t99 x li I ~i I e + t99 x I i  and the errors on 
the V,  K,, Ki and K' values were estimated from these 
interval values. 
Comparison between Non-competitive 
and Competitive Models 
Assuming that during the interaction between 
enzyme, penicillin and substrate, the ternary complex 
EIS is not formed, the model is competitive. The V, 
K ,  and Ki values can also be measured on the basis 
of Eqn (2) in which, however, the dz term is eliminated 
(K' = cc and therefore d = 0). 
In order to determine which of the non-competitive 
(NC) or competitive (C) models best fits the data, the 
Fisher-Snedecor variable (F) was calculated from 
(tNC - tc) (n - 4) 
n - f N C  
F =  
with tNC - tc = (n - 3)  (sZOR)C - (n  - 4) (&R)NC 
and n - tNC = (n - 4) (&R)NC. 
The higher the Fvalue, the higher is the probability 
that a non-competitive model represents the real 
mechanism involved. 
RESULTS 
Interaction between Enzyme, Substrate 
UDP-MurNAc-LAla-DGlu (Azpm-oAla-DA la) 
and P-Lactam Antibiotics 
The amounts of D-alanine formed by the L-form 
DD-carboxypeptidase from the substrate was followed 
in 25 mM Na Hepes buffer pH 7.8 with 0.5% (w/v) 
Genapol X-100. Four sets of experiments were carried 
out under the conditions described in Table 1. In 
all cases where antibiotic was present, the plots of 
amount of D-alanine released versus time gave rise 
to straight lines which extrapolated at positive values 
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Fig. 1. Time course of' release of' o-ulunine from I .25 mM substrate 
UDP-MurNAc-pentupeptide by L-form DD-carboxypeptidase in 
25 mM Na Hepes, pH 7.8, with 0.5% (wlv) Genupol X-100 at 
37 "C and in the presence of various concentrations ofbenzylpenicillin 
and in the absence of antibiotic. The slopes of the linear part of the 
progress curves were computed by linear regression analysis 
on the ordinate axis (Fig. 1). The burst thus observed 
at the onset of the reaction was due to the fact that it 
took about 2-3 min for the steady state to be estab- 
lished and it indicated that formation of complex 
EI* was a relatively slow process. After the burst, 
the steady-state velocity values (v) remained constant 
throughout the experiments. No sign of reacceleration 
of the reaction was observed indicating that, although 
the antibiotic was destroyed during the reaction, its 
concentration remained largely higher than the enzyme 
concentration. 
Table 2 gives the residual variance values (S&R)C 
and (S&)NC for competitive and non-competitive 
models, respectively, and the Fisher-Snedecor variable 
F values. On the basis of the percentiles of the F 
distribution, the non-competitive model appears to 
be highly probable with levels of confidence of 
90-95 % for two sets of experiments and higher than 
99 % for two other sets of experiments. 
Table 3 gives the values of the various parameters 
V,  K,, Ki and K' involved in a non-competitive type 
of interaction. From the corresponding confidence 
intervals (t99 x li, also shown in Table 3), the K, 
value for substrate is between 0.08 and 0.56 mM, the 
Ki value for benzylpenicillin is between 0.04 and 
0.15 pM and the K' value also for benzylpenicillin is 
lower than 2.7 pM. With carbenicillin, the correspond- 
ing Ki value is 1.14 f 0.50 pM and the corresponding 
K' value is 36 & 27 pM. 
The k" values for the breakdown of complexes 
EI* formed with benzylpenicillin and carbenicillin, 
respectively, were determined from the recovery times 
Table 2. Comparison between competitive and non-competitive models 
for the interaction between enzyme, substrate and penicillin 
The level of confidence for the choice of a non-competitive (NC) 
model was on the basis of the percentiles of the F distribution 
Expt (&R)c (S&C Fisher- Level of con- 
Snedecor fidence for 
variable F the choice of 
NC model 
1 0.03191 0.01754 16 > 99 
2 0.01342 0.01143 3.8 90 - 95 
3 0.01343 0.01222 4.07 90-95 
4 0.00996 0.00557 16.8 > 99 
t in time courses of reappearance of DD-CarbOXy- 
peptidase activity after enzyme inactivation by the 
corresponding 0-lactamase and subsequent hydrolysis 
of the excess of antibiotic by penicillinase [3]. At 37 "C, 
the k4 value was 3.3 x l op3  s-' for benzylpenicillin 
(half-life of the complex = 3.5 rnin). From the K' 
and k4 values and by assuming k3 9 k", the k3/K 
value for formation of complex EI* was between 2 
and 8 x lo" M-' s-'. 
Nature of the Degradation Product Arising 
from the Interaction between '"C-Labelled 
and 3H-Labelled Penicillins and the Enzyme 
The degradation product was characterized sub- 
sequent to the breakdown of labelled penicillin and 
accumulation of the antibiotic metabolite in the 
course of the fast reaction of a given quantity of DD- 
carboxypeptidase with several consecutively added 
samples of penicillin. Alternatively, the antibiotic 
metabolite was obtained by release from the isolated 
enzyme-inhibitor complex EI*. At low temperature 
EI* was sufficiently stable to permit its separation 
from the reaction mixture. 
In the first case, 118 mU DD-carboxypeptidase in 
1 ml 50 mM Hepes buffer, pH 7.8, with 5 % Genapol 
X-100, were incubated at 37 "C with 1.5 nmol ['"CI- 
benzylpenicillin (containing 8 1 nCi of radioactive 
label). Further samples of 0.8 nmol labelled penicillin 
were added at time intervals of 3.5 min with a total 
input of 43 nmol antibiotic containing 2.3 pCi of 
radioactivity within 3 h. The accumulated degrada- 
tion product was purified and separated from reactivat- 
ed DD-carboxypeptidase by gel filtration on a 
15x 1.5-cm column of Sephadex G-25 fine in the 
cold and was characterized by thin-layer chromatog- 
raphy in solvents a, b and c and by high-voltage paper 
electrophoresis. One major radioactive metabolite 
was found. Its RF values (solvent a, 0.58; b, 0.48 and c, 
0.040) and migration distance of 33 cm after electro- 
phoresis for 90 min at 60 V/cm coincided with those 
of authentic benzylpenicilloic acid. The above result 
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Table 3. Values with confidence intervals (t99 x li) ofthe various constants involved in the non-competitive interuction between enzyme, suh.ctr.ate 
and penicillin 
Expt Antibiotic V K,  Ki K' 
pmol min-' mg-' mM PM 
1.05 1.35 1.26 k 1.45 1 Benzylpenicillin 0.17 k 0.065 0.62 k 0.56 
3 Benzy lpenicillin 0.80 0.11 0.32 k 0.24 0.086 _+ 0.06 4.7 k 6.1 
2 Benzylpenicillin 0.56 k 0.24 1.95 & 2.15 0.59 k 0.55 1.02 * 2.00 
0.08 < K,,, < 0.56 0.04 < Ki < 0.15 K' < 2.7 
4 Carbenicillin 0.78 & 0.09 0.32 0.15 1.14 +_ 0.50 36 k 27 
- _ _ _ - - _ _ . _ _ _ ~ ~ - ~ ~ _ _ ~  ~ _ _ _ _ _ _ _ _ ~ _ _  
was confirmed in a more detailed analysis of a sample 
of antibiotic metabolite corresponding to 55 nCi 
labelled antibiotic by column chromatography in a 
lithium citrate gradient on Chromobeads type B 
cation-exchange resin [ll,  121. Here again, benzyl- 
penicilloic acid was identified as the main degradation 
product, but other metabolites such as phenylacetyl- 
glycine and phenylacetic acid were also present in 
smaller amounts. 
For the preparation of the antibiotic metabolite 
by release from the isolated EI* complex, 55 mU 
DD-carboxypeptidase in 1 ml 50 mM Hepes buffer, 
pH 7.8, containing 5 % (w/v) Genapol X-100, were 
incubated for 10 min at  37 "C with either 30 nmol 
I4C-labelled benzylpenicillin containing 1.63 pCi of 
radioactivity or 45 nmol phen~xymethyl[~H]penicillin 
with 4.5 pCi of radioactivity. Then the mixture were 
cooled to 4 "C and the EI* complexes formed were 
separated from unbound labelled antibiotic by gel 
filtration on a 15 x 1.5-cm column of Sephadex G-25 
fine in the cold. Release of the antibiotic metabolites 
from the complexes was obtained by incubation for 
20 min at 37 "C. 
Analysis of the penicillin degradation products 
was carried out by chromatography on a Chromo- 
beads type B cation-exchange column as described. 
Quantitative yields of radioactive products varied in 
different experiments but ['4C]benzylpenicilloic acid 
(85  % of the radioactivity extracted by ethyl acetate 
in one experiment) and phenoxymethyl[3H]penicilloic 
acid (80 % of the radioactivity extracted), respectively, 
were the predominating metabolites in all cases. In 
addition, smaller amounts of other radioactive com- 
pounds were also obtained, such as phenylacetyl- 
glycine (8 %) and phenylacetic acid (6 %) from ['"CI- 
benzylpenicillin and N-formyl-D-penicillamine (7 %) 
from phen~xymethyl[~H]penicillin. However, minor 
compounds were also present in comparable amounts 
in a reaction mixture where ['4C]benzylpenicillin had 
been converted quantitatively into benzylpenicilloic 
acid by the action of penicillinase with or without 
further addition of DD-carboxypeptidase. Therefore, 
these compounds may be products of a further 
metabolism of penicilloic acid formed during the 
various manipulations and/or may be present as 
contaminants of the labelled penicillins, as has been 
shown for phenylacetic acid. 
From the foregoing, the action of Proteus L-form 
Du-carboxypeptidase on penicillins can be interpreted 
as that of a slow penicillinase. It is unlikely that the 
slow production of penicilloic acid by DD-carboxy- 
peptidase is due to the presence of trace amounts of 
another classical 8-lactamase in the purified DD- 
carboxypeptidase preparation, because fi-lactamase 
has previously been found to be totally absent from 
spheroplasts of the unstable Proteus L-form and from 
crude membrane-bound or solubilized DD-CarbOXy- 
peptidase of this organism. Also, even on prolonged 
interaction purified L-form DD-carboxypeptidase did 
not give any detectable reaction with chromogenic 
cephalosporin 87-3 12, [3-(2,4-dinitrostyry1)-(6R, 7R)-7- 
(2-thienylacetamido)-ceph-3-em-4-carboxylic acid, E 
isomer], a highly sensitive detector of P-lactamases 
PI. 
DISCUSSION 
In previous work with the purified L-form DD- 
carboxypeptidase, Lineweaver-Burk plots with the 
characteristics of non-competitive inhibition by peni- 
cillin and carbenicillin had already been obtained 
using individual measurements of initial velocities 
[ 3 ] .  The present statistical analyses made with the 
help of a linear regression program especially devised 
for the purpose (and referred to as BRUNO program) 
confirmed these preliminary data and hence support 
the conclusion that the ternary complex EIS is actually 
formed during the interaction between enzyme, sub- 
strate and p-lactam antibiotic. The present study did 
not establish whether or not this ternary complex 
EIS could give rise to degraded peptide, P. Dixon 
plots (not shown) of the actual experimental data did 
not show signs of hyperbolic non-competitive inhibi- 
tion, suggesting that EIS was a dead-end complex. 
With all the DD-carboxypeptidases-transpeptidases 
formerly examined, including both exocellular R61 
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and R39 enzymes, the inhibition appeared to be of the 
competitive type at least by graphical analyses [4 - 61. 
As amply discussed elsewhere [13,14], these results 
are not persuasive. They only indicate that under the 
experimental conditions used (or rather imposed 
because of technical limitations), [EIS] is < [EI] 
The interaction between the L-form DD-CarbOXy- 
peptidase and penicillin is characterized by a rapid 
formation of complex EI* (high k3/K values) and the 
subsequent dissociation of this labile complex at 
fairly high velocity with enzyme reactivation and 
conversion of penicillin to penicilloic acid. This rapid 
degradation of penicillin confers to the DD-carboxy- 
peptidase a high resistance to penicillin which may be 
relevant to the continued function in the L-form 
organism during growth in the presence of penicillin. 
Penicillin binding protein 5 of Escherichia coli K 12 
(a DD-carboxypeptidase) also forms with benzyl- 
penicillin a transient complex of short half-life (5 min 
at 30 "C) [ 151. 
+ [EI*]. 
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